Intercept Pharmaceuticals Inc Market cap
What is the Market cap of Intercept Pharmaceuticals Inc?
The Market cap of Intercept Pharmaceuticals Inc is $460.93M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with market cap similar to Intercept Pharmaceuticals Inc
- Carter Bank & Trust has Market cap of $459.11M
- Custom Truck One Source Inc has Market cap of $459.62M
- Gateway Distriparks has Market cap of $460.03M
- Similarweb has Market cap of $460.69M
- I.T has Market cap of $460.69M
- PM Capital Global Opportunities Fund has Market cap of $460.80M
- Intercept Pharmaceuticals Inc has Market cap of $460.93M
- Pierre & Vacances SA has Market cap of $461.00M
- Smith & Wesson Brands has Market cap of $461.24M
- Cardinal Resources has Market cap of $461.84M
- Invesco Mortgage Capital Inc has Market cap of $461.86M
- Greatland Gold Plc has Market cap of $461.87M
- Misonix Inc has Market cap of $461.98M